openPR Logo
Press release

Investigation announced for Investors in shares of PolarityTE, Inc. (NASDAQ: PTE)

09-03-2021 02:55 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in PolarityTE, Inc. (NASDAQ: PTE) shares over potential securities laws violations by PolarityTE.

An investigation for investors in PolarityTE, Inc. (NASDAQ: PTE) shares over potential securities laws violations by PolarityTE.

An investigation was announced over potential securities laws violations by PolarityTE, Inc. and certain of its directors and officers in connection with certain financial statements.

Investors who purchased shares of PolarityTE, Inc. (NASDAQ: PTE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of PolarityTE, Inc. (NASDAQ: PTE) concerning whether a series of statements by PolarityTE, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Salt Lake City, UT based PolarityTE, Inc., a biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States.

On August 24, 2021, PolarityTE, Inc. issued a press release "provid[ing] an update regarding correspondence from the U.S. Food and Drug Administration (FDA) related to its Investigational New Drug Application (IND) for SkinTE® with a proposed indication for chronic cutaneous ulcers, which was filed on July 23, 2021. The FDA provided feedback that certain Chemistry, Manufacturing, and Control (CMC) items need to be addressed prior to proceeding with a pivotal study. As a result, the study proposed in the IND has been placed on clinical hold. In accordance with standard practice and regulations, the FDA has advised that it will issue a clinical hold letter providing details on the basis for the hold to the Company by September 21, 2021."

Shares of PolarityTE, Inc. (NASDAQ: PTE) declined to $0.64 per share on August 24, 2021.

Those who purchased shares of PolarityTE, Inc. (NASDAQ: PTE) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of PolarityTE, Inc. (NASDAQ: PTE) here

News-ID: 2379389 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for PolarityTE

Chronic Wounds Market Dynamics Indicate Upward Trajectory Through 2034, Reports …
The Key Chronic Wounds Companies in the market include - Paracrine, Inc, Oneness Biotech, MediWound, PolarityTE, and others. The Chronic Wounds market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Wounds pipeline products will significantly revolutionize the Chronic Wounds market dynamics. DelveInsight's "Chronic Wounds Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Chronic Wounds,
Chronic Wounds Market Growth Projections 2024-2034: DelveInsight Analysis | Para …
The Chronic Wounds market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Wounds pipeline products will significantly revolutionize the Chronic Wounds market dynamics. DelveInsight's "Chronic Wounds Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Wounds, historical and forecasted epidemiology as well as the Chronic Wounds market trends in the United States,
Chronic Wounds Market Growth Projections 2024-2034: DelveInsight Analysis | Para …
The Chronic Wounds market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Wounds pipeline products will significantly revolutionize the Chronic Wounds market dynamics. DelveInsight's "Chronic Wounds Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Wounds, historical and forecasted epidemiology as well as the Chronic Wounds market trends in the United States,
Investigation announced for Long-Term Investors in shares of PolarityTE, Inc. (N …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of PolarityTE, Inc. Investors who are current long term investors in PolarityTE, Inc. (NASDAQ: PTE) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: PTE stocks follows a lawsuit filed against PolarityTE, Inc. over
Deadline on Nov. 23rd coming up in Lawsuit for Investors in PolarityTE, Inc. (NA …
A deadline is coming up on November 23, 2021 in the lawsuit filed for certain investors of PolarityTE, Inc. (NASDAQ: PTE) over alleged securities laws violations by PolarityTE, Inc. Investors who purchased shares of PolarityTE, Inc. (NASDAQ: PTE) have certain options and there are strict and short deadlines running. Deadline: November 23, 2021. NASDAQ: PTE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Lawsuit filed for Investors in shares of PolarityTE, Inc. (NASDAQ: PTE)
An investor, who purchased shares of PolarityTE, Inc. (NASDAQ: PTE), filed a lawsuit over alleged violations of Federal Securities Laws by PolarityTE, Inc. in connection with certain allegedly false and misleading statements made between April 30, 2020 and August 23, 2021. Investors who purchased shares of PolarityTE, Inc. (NASDAQ: PTE) have certain options and for certain investors are short and strict deadlines running. Deadline: November 23, 2021. NASDAQ: PTE investors should